机译:广泛中和的HIV-1抗体与Founder病毒共同进化
Duke University Human Vaccine Institute, Departments of Medicine and Immunology, Duke University School of Medicine, Durham, North Carolina 27710, USA,Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Durham, North Carolina 27710, USA;
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA;
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA;
Duke University Human Vaccine Institute, Departments of Medicine and Immunology, Duke University School of Medicine, Durham, North Carolina 27710, USA,Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Durham, North Carolina 27710, USA;
Duke University Human Vaccine Institute, Departments of Medicine and Immunology, Duke University School of Medicine, Durham, North Carolina 27710, USA,Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Durham, North Carolina 27710, USA;
机译:A1?病毒 - 抗体共同作用在v3-聚糖指导的HIV-1广泛中和抗体谱系中的作用
机译:Myomedin支架变体靶向10E8 HIV-1宽度中和抗体模拟GP41表位和小鼠中的引发HIV-1病毒中和血清
机译:交叉反应性HIV-1中和性单克隆抗体,可通过筛选针对人包膜糖蛋白(gp140)的免疫人噬菌体文库进行筛选,该包膜糖蛋白从具有广泛HIV-1中性抗体的患者(R2)中分离。
机译:靶向靶向HIV-1包络CD4结合位点的宽度中和抗体的结构引导工程
机译:广泛中和抗体和广泛中和血清:对HIV-1疫苗设计的见解
机译:广泛中和的HIV-1抗体与Founder病毒共同进化
机译:广泛中和的HIV-1抗体和建立者病毒的共同进化。